Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Major Shareholder Sells $40,170.00 in Stock

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) major shareholder Fosun Pharmaceutical Shanghai sold 3,000 shares of Nature’s Sunshine Products stock in a transaction that occurred on Thursday, October 10th. The shares were sold at an average price of $13.39, for a total value of $40,170.00. Following the transaction, the insider now owns 69,347 shares of the company’s stock, valued at approximately $928,556.33. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Fosun Pharmaceutical Shanghai also recently made the following trade(s):

• On Monday, October 14th, Fosun Pharmaceutical Shanghai sold 1,300 shares of Nature’s Sunshine Products stock. The shares were sold at an average price of $13.12, for a total transaction of $17,056.00.
• On Tuesday, October 8th, Fosun Pharmaceutical Shanghai sold 1,800 shares of Nature’s Sunshine Products stock. The shares were sold at an average price of $13.13, for a total value of $23,634.00.
• On Tuesday, October 1st, Fosun Pharmaceutical Shanghai sold 1,399 shares of Nature’s Sunshine Products stock. The shares were sold at an average price of $13.54, for a total value of $18,942.46.

Nature’s Sunshine Products Price Performance

Shares of NATR stock traded down $0.13 during trading on Tuesday, hitting $12.89. 2,700 shares of the stock traded hands, compared to its average volume of 53,973. The firm’s fifty day moving average price is $13.42 and its 200-day moving average price is $15.53. The firm has a market capitalization of $241.43 million, a P/E ratio of 15.32 and a beta of 0.87. Nature’s Sunshine Products, Inc. has a 52-week low of $10.81 and a 52-week high of $21.72.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.18). Nature’s Sunshine Products had a return on equity of 9.79% and a net margin of 3.50%. The business had revenue of $110.55 million for the quarter.

Analyst Ratings Changes

Several research firms have issued reports on NATR. StockNews.com raised shares of Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a report on Tuesday, September 10th. DA Davidson lowered their price target on shares of Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, August 12th. Canaccord Genuity Group started coverage on Nature’s Sunshine Products in a report on Friday, September 13th. They issued a “buy” rating and a $18.00 price target for the company. Finally, Canaccord Genuity Group assumed coverage on Nature’s Sunshine Products in a research note on Friday, September 13th. They set a “buy” rating and a $18.00 price objective on the stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. Wasatch Advisors LP raised its holdings in shares of Nature’s Sunshine Products by 20.6% in the 1st quarter. Wasatch Advisors LP now owns 518,161 shares of the company’s stock valued at $10,762,000 after buying an additional 88,433 shares during the period. Paradigm Capital Management Inc. NY increased its stake in Nature’s Sunshine Products by 26.8% during the second quarter. Paradigm Capital Management Inc. NY now owns 695,079 shares of the company’s stock worth $10,475,000 after purchasing an additional 146,879 shares during the period. Janney Montgomery Scott LLC increased its stake in Nature’s Sunshine Products by 8.9% during the first quarter. Janney Montgomery Scott LLC now owns 25,200 shares of the company’s stock worth $523,000 after purchasing an additional 2,054 shares during the period. Panagora Asset Management Inc. boosted its stake in shares of Nature’s Sunshine Products by 8.3% in the second quarter. Panagora Asset Management Inc. now owns 70,338 shares of the company’s stock valued at $1,060,000 after purchasing an additional 5,392 shares during the period. Finally, Lazard Asset Management LLC grew its holdings in shares of Nature’s Sunshine Products by 16.5% in the first quarter. Lazard Asset Management LLC now owns 7,040 shares of the company’s stock valued at $146,000 after purchasing an additional 998 shares in the last quarter. 79.40% of the stock is currently owned by institutional investors and hedge funds.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.